PEPTIDES BASED ON THE TRANSMEMBRANE DOMAIN OF A TOLL-LIKE RECEPTOR (TLR) FOR TREATMENT OF TLR-MEDIATED DISEASES

PEPTIDES BASED ON THE TRANSMEMBRANE DOMAIN OF A TOLL-LIKE RECEPTOR (TLR) FOR TREATMENT OF TLR-MEDIATED DISEASES

Peptides are provided that are capable of inhibiting cell activation mediated by a Toll-like receptor (TLR) selected from TLR 1, 2, 4 or 6, said peptide comprising a sequence consisting of, or found within, the sequence of the transmembrane domain of a TLR selected from TLR 1, 2, 4 or 6 and optional...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SHMUEL-GALIA, LIRAZ, FINK, AVNER, REUVEN, ELIRAN-MOSHE, SHAI, YECHIEL
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SHMUEL-GALIA, LIRAZ
FINK, AVNER
REUVEN, ELIRAN-MOSHE
SHAI, YECHIEL
description Peptides are provided that are capable of inhibiting cell activation mediated by a Toll-like receptor (TLR) selected from TLR 1, 2, 4 or 6, said peptide comprising a sequence consisting of, or found within, the sequence of the transmembrane domain of a TLR selected from TLR 1, 2, 4 or 6 and optionally cytoplasmic and extracellular regions flanking the transmembrane domain. These peptides as well as pharmaceutical composition comprising them are useful for the treatment of TLR-mediated disease.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2596009A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2596009A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2596009A13</originalsourceid><addsrcrecordid>eNqNjb8KwjAYxLs4iPoO36hDoCoKHdPmSoP5U5JvL0XiJLZQ3x8j-ABOdxy_u1sXU4-etUKkWkYo8o64A3GQLlrYOitIeSu1I9-SJPbGCKNvoIAmd32gPZtwoDY7DpBs4fjL5lRYKC057yodkQ_itlg9xueSdj_dFNSCm06keRrSMo_39ErvAf3pUl3LspLH8x_IB9SXNoU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PEPTIDES BASED ON THE TRANSMEMBRANE DOMAIN OF A TOLL-LIKE RECEPTOR (TLR) FOR TREATMENT OF TLR-MEDIATED DISEASES</title><source>esp@cenet</source><creator>SHMUEL-GALIA, LIRAZ ; FINK, AVNER ; REUVEN, ELIRAN-MOSHE ; SHAI, YECHIEL</creator><creatorcontrib>SHMUEL-GALIA, LIRAZ ; FINK, AVNER ; REUVEN, ELIRAN-MOSHE ; SHAI, YECHIEL</creatorcontrib><description>Peptides are provided that are capable of inhibiting cell activation mediated by a Toll-like receptor (TLR) selected from TLR 1, 2, 4 or 6, said peptide comprising a sequence consisting of, or found within, the sequence of the transmembrane domain of a TLR selected from TLR 1, 2, 4 or 6 and optionally cytoplasmic and extracellular regions flanking the transmembrane domain. These peptides as well as pharmaceutical composition comprising them are useful for the treatment of TLR-mediated disease.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130529&amp;DB=EPODOC&amp;CC=EP&amp;NR=2596009A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130529&amp;DB=EPODOC&amp;CC=EP&amp;NR=2596009A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHMUEL-GALIA, LIRAZ</creatorcontrib><creatorcontrib>FINK, AVNER</creatorcontrib><creatorcontrib>REUVEN, ELIRAN-MOSHE</creatorcontrib><creatorcontrib>SHAI, YECHIEL</creatorcontrib><title>PEPTIDES BASED ON THE TRANSMEMBRANE DOMAIN OF A TOLL-LIKE RECEPTOR (TLR) FOR TREATMENT OF TLR-MEDIATED DISEASES</title><description>Peptides are provided that are capable of inhibiting cell activation mediated by a Toll-like receptor (TLR) selected from TLR 1, 2, 4 or 6, said peptide comprising a sequence consisting of, or found within, the sequence of the transmembrane domain of a TLR selected from TLR 1, 2, 4 or 6 and optionally cytoplasmic and extracellular regions flanking the transmembrane domain. These peptides as well as pharmaceutical composition comprising them are useful for the treatment of TLR-mediated disease.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjb8KwjAYxLs4iPoO36hDoCoKHdPmSoP5U5JvL0XiJLZQ3x8j-ABOdxy_u1sXU4-etUKkWkYo8o64A3GQLlrYOitIeSu1I9-SJPbGCKNvoIAmd32gPZtwoDY7DpBs4fjL5lRYKC057yodkQ_itlg9xueSdj_dFNSCm06keRrSMo_39ErvAf3pUl3LspLH8x_IB9SXNoU</recordid><startdate>20130529</startdate><enddate>20130529</enddate><creator>SHMUEL-GALIA, LIRAZ</creator><creator>FINK, AVNER</creator><creator>REUVEN, ELIRAN-MOSHE</creator><creator>SHAI, YECHIEL</creator><scope>EVB</scope></search><sort><creationdate>20130529</creationdate><title>PEPTIDES BASED ON THE TRANSMEMBRANE DOMAIN OF A TOLL-LIKE RECEPTOR (TLR) FOR TREATMENT OF TLR-MEDIATED DISEASES</title><author>SHMUEL-GALIA, LIRAZ ; FINK, AVNER ; REUVEN, ELIRAN-MOSHE ; SHAI, YECHIEL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2596009A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>SHMUEL-GALIA, LIRAZ</creatorcontrib><creatorcontrib>FINK, AVNER</creatorcontrib><creatorcontrib>REUVEN, ELIRAN-MOSHE</creatorcontrib><creatorcontrib>SHAI, YECHIEL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHMUEL-GALIA, LIRAZ</au><au>FINK, AVNER</au><au>REUVEN, ELIRAN-MOSHE</au><au>SHAI, YECHIEL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PEPTIDES BASED ON THE TRANSMEMBRANE DOMAIN OF A TOLL-LIKE RECEPTOR (TLR) FOR TREATMENT OF TLR-MEDIATED DISEASES</title><date>2013-05-29</date><risdate>2013</risdate><abstract>Peptides are provided that are capable of inhibiting cell activation mediated by a Toll-like receptor (TLR) selected from TLR 1, 2, 4 or 6, said peptide comprising a sequence consisting of, or found within, the sequence of the transmembrane domain of a TLR selected from TLR 1, 2, 4 or 6 and optionally cytoplasmic and extracellular regions flanking the transmembrane domain. These peptides as well as pharmaceutical composition comprising them are useful for the treatment of TLR-mediated disease.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP2596009A1
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title PEPTIDES BASED ON THE TRANSMEMBRANE DOMAIN OF A TOLL-LIKE RECEPTOR (TLR) FOR TREATMENT OF TLR-MEDIATED DISEASES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A54%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHMUEL-GALIA,%20LIRAZ&rft.date=2013-05-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2596009A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true